OncoCyte Corp (NAS:OCX)
$ 2.16 -0.03 (-1.37%) Market Cap: 36.36 Mil Enterprise Value: 36.99 Mil PE Ratio: 0 PB Ratio: 2.98 GF Score: 32/100

Q2 2020 OncoCyte Corp Earnings Call Transcript

Jul 29, 2020 / 08:30PM GMT
Release Date Price: $27.4 (-4.20%)
Operator

Greetings, and welcome to Oncocyte Corporation Second Quarter 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to introduce your host, Bob Yedid, Managing Director of LifeSci Advisors. Thank you. You may begin.

Robert A. Yedid
LifeSci Advisors, LLC - MD

Thank you, Doug, and thank you, everyone, for joining us for today's conference call to discuss Oncocyte's Second Quarter 2020 Financial Results and Recent Operating Highlights. If you have not seen today's financial results press release, please visit the company's website and look at the Investors page.

Before turning the call over to Ronnie Andrews, Oncocyte's President and Chief Executive Officer, I'd like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. Any statements that are not historical facts are forward-looking statements. We encourage you to review the company's SEC filings, including, without limitation, the company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot